Akari Therapeutics (AKTX) Interest Expenses (2011 - 2026)

Akari Therapeutics (AKTX) reported Interest Expenses of $100000.0 for Q1 2026, little changed on a YoY basis from $100000.0 in Q1 2025, and up 10100.0% sequentially from -$1000.0 in Q4 2025.

Akari Therapeutics (AKTX) Interest Expenses (2011 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 11 years of Interest Expenses data on file, last reported at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $195000.0 (up 30.87% YoY), and the FY2025 full-year result was $63.4 million, up 63256.0% from the prior year.
  • Interest Expenses rose to $100000.0 in Q1 2026, from -$1000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $34.6 million in Q4 2022 to a low of -$20000.0 in Q4 2024.
  • A 5-year average of $3.9 million and a median of $69000.0 in 2024 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses slumped 211.11% in 2024 and jumped 95.0% in 2025, its largest moves.
  • Tracing AKTX's Interest Expenses over 5 years: stood at $34.6 million in 2022, then tumbled by 99.95% to $18000.0 in 2023, then tumbled by 211.11% to -$20000.0 in 2024, then jumped by 95.0% to -$1000.0 in 2025, then jumped by 10100.0% to $100000.0 in 2026.
  • Business Quant data shows AKTX's Interest Expenses at $100000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$4000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 69.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 -1,000.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 -4,000.00
Sep 30, 2025 -4,000.00
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 -20,000.00
Dec 31, 2024 -20,000.00
Sep 30, 2024 69,000.00
Sep 30, 2024 69,000.00
Dec 31, 2023 18,000.00
Dec 31, 2023 18,000.00
Dec 31, 2022 34.62 Mn
Dec 31, 2022 34.62 Mn
Dec 31, 2021 30.32 Mn
Dec 31, 2021 30.32 Mn